Opthea Limited (OPT)
NASDAQ: OPT · Real-Time Price · USD
2.890
-0.100 (-3.34%)
At close: Sep 6, 2024, 4:00 PM
3.020
+0.130 (4.50%)
After-hours: Sep 6, 2024, 5:06 PM EDT
Opthea Market Cap
Opthea has a market cap or net worth of $440.21 million as of September 6, 2024. Its market cap has increased by 209.57% in one year.
Market Cap
440.21M
Enterprise Value
468.41M
1-Year Change
209.57%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since the IPO on October 16, 2020, Opthea's market cap has decreased from $582.45M to $440.21M, a decrease of -24.42%. That is a compound annual growth rate of -6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 394.30M | 128.85% |
| Dec 29, 2023 | 172.30M | -26.96% |
| Dec 30, 2022 | 235.90M | -28.73% |
| Dec 31, 2021 | 331.00M | -31.27% |
| Dec 31, 2020 | 481.60M | -17.32% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 454.78M |
| COMPASS Pathways | 453.07M |
| ZimVie | 443.08M |
| Health Catalyst | 440.83M |
| Altimmune | 440.28M |
| Anavex Life Sciences | 436.27M |
| Pacific Biosciences of California | 430.60M |
| Contineum Therapeutics | 428.29M |